Medroxyprogesterone acetate linked to immune suppression

Medroxyprogesterone acetate linked to immune suppression
Use of the injectable contraceptive depot medroxyprogesterone acetate, common in areas such as sub-Saharan Africa with high HIV-1 prevalence, is associated with suppression of the immune response, according to a study published online Jan. 25 in Endocrinology.

(HealthDay)—Use of the injectable contraceptive depot medroxyprogesterone acetate (MPA), common in areas such as sub-Saharan Africa with high HIV-1 prevalence, is associated with suppression of the immune response, according to a study published online Jan. 25 in Endocrinology.

Noting that observational studies indicate a correlation between hormonal contraceptives and acquisition and transmission of HIV-1, Richard P.H. Huijbregts, from the University of Alabama at Birmingham, and colleagues examined the effect of MPA and other hormones on innate and adaptive immune mechanisms.

The researchers found that, in and activated T cells, MPA inhibited many cytokines and chemokines, including interferon (IFN)-γ and (TNF)-α. produced less IFN-γ and TNF-α in response to ligands to several Toll-like receptors after MPA treatment. Use of depot MPA was associated with lower levels of IFN-γ in plasma and genital secretions. Lastly, the investigators found that MPA treatment blocked the down-regulation of the HIV-1 coreceptors CXCR4 and CCR5 after T cell activation and increased replication of HIV-1 in activated .

"The presented results suggest that MPA suppresses both innate and adaptive arms of the immune system resulting in a reduction of host resistance to invading pathogens," Huijbregts and colleagues conclude.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Scientists disarm HIV in step towards vaccine

Sep 19, 2011

Researchers have found a way to prevent HIV from damaging the immune system, in a new lab-based study published in the journal Blood. The research, led by scientists at Imperial College London and Johns Hopkins University, ...

New HIV-inhibiting protein identified

May 29, 2012

Scientists have identified a new HIV-suppressing protein in the blood of people infected with the virus. In laboratory studies, the protein, called CXCL4 or PF-4, binds to HIV such that it cannot attach to or enter a human ...

Oregon study raises questions on synthetic progestins

Mar 10, 2008

The widely used synthetic progestin medroxyprogesterone acetate (MPA) decreased endothelial function in premenopausal women in a study done at the University of Oregon. The finding, researchers said, raises concerns about ...

Recommended for you

Sublingual immunotherapy tablet safe in asthma patients

13 minutes ago

(HealthDay)—For individuals with asthma and allergic rhinitis with/without conjunctivitis (AR/C), treatment with a Timothy grass sublingual immunotherapy tablet (SLIT-tablet) seems safe, according to research ...

Could trophoblasts be the immune cells of pregnancy?

Dec 18, 2014

Trophoblasts, cells that form an outer layer around a fertilized egg and develop into the major part of the placenta, have now been shown to respond to inflammatory danger signals, researchers from Norwegian University of ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.